4
Participants
Start Date
April 30, 2010
Primary Completion Date
September 30, 2010
Study Completion Date
December 31, 2010
Radiolabeled (99Tc) EC-DG (ethylenedicysteine-deoxyglucose)
one injection of Technetium ethylenedicysteine-deoxyglucose to yield a target activity of 20 mCi (range 20-30 mCi) to be given by slow IV push (over 3-5 minutes) 1mg of EC-DG will be injected
Technetium 99m ethylenedicysteine-deoxyglucose
99mTc EC-DG injection, single dose, slow IV push over 3-5 minutes, yielding a target activity of 20 mCi (range 20-30 mCi)
18 F fluorodeoxyglucose
single injection of 18F FDG (range 10-20 mCi)
Montefiore Medical Center, The Bronx
Mayo Clinic, Division of Nuclear Medicine, Rochester
University of Chicago, Chicago
Lead Sponsor
Collaborators (3)
Numoda
INDUSTRY
Venn Life Sciences
OTHER
Camargo Pharmaceutical Services
INDUSTRY
Biomedical Systems
INDUSTRY
Cell>Point LLC
INDUSTRY